Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/19/25 20:49 | 3/17/25 | RDNT | Health | Health | Medical Laboratories | Hames Norman R | CA | O | P,COO-We | 2 | S.dm | -862 | 31.98 | 0 | -27 | 256 | D | |||||||||||||||
3/11/25 21:31 | 3/7/25 | RDNT | Health | Health | Medical Laboratories | Swartz David L | CA | D | 1 | S | -1,271 | 50.84 | 0 | -25 | 211 | D | ||||||||||||||||
3/10/25 16:15 | 1/4/25 | RDNT | Health | Health | Medical Laboratories | Katz David Jeffrey | CA | O | EVP,GC | 1 | M.dm | 0 | 0.00 | 0 | 17 | 19 | 104 | D | ||||||||||||||
3/7/25 19:18 | 3/5/25 | RDNT | Health | Health | Medical Laboratories | Wesdorp Cornelis | CA | O | P,CEO,Di | 1 | S.m | -258 | 51.63 | 0 | -5 | 56 | D | |||||||||||||||
3/6/25 16:15 | 3/5/25 | RDNT | Health | Health | Medical Laboratories | Berger Howard G | CA | DO | P,CEO | 1 | M.d | 0 | 0.00 | 0 | 54 | 33 | 218 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |